Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000027014 |
|---|---|
| Receipt number | R000030974 |
| Scientific Title | The follow up study of "Phase l / ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type (JACCRO CC-06)". |
| Date of disclosure of the study information | 2017/04/18 |
| Last modified on | 2019/03/08 10:14:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/04/17 11:29:11 | ||
| 2 | Update | 2018/01/17 12:06:00 | Recruitment status |
|
| 3 | Update | 2019/03/08 10:14:22 | Recruitment status Date trial data considered complete Date analysis concluded |